Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects

被引:0
|
作者
Weber, AA
Liesener, S
Schanz, A
Hohlfeld, T
Schrör, K
机构
[1] Univ Dusseldorf, Inst Pharmakol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Klin Pharmakol, D-40225 Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present study investigates the effects of aspirin (100 mg every second day for 14 days) on platelet function in nine healthy non-smokers and in nine healthy habitual smokers, There was a significantly (P<0.05) stronger inhibition of collagen (0.61 mu g/ml)- and ADP (2 mu M)-induced platelet aggregation by aspirin in smokers as compared to non-smokers. This difference occurred in the presence of an almost complete (>95%) inhibition of thromboxane A(2) (TXA(2)) synthesis in both groups, The platelet capacity to generate TXA(2) in vitro was significantly reduced in smokers, urinary excretion of TXA(2), however, was significantly increased. Thus, the better susceptibility of smokers to anti-aggregatory effects of aspirin is very likely to be related to a chronic smoking-induced alteration of platelet TXA(2) system. Cessation of smoking should, therefore, be encouraged.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 48 条
  • [41] DIFFERENTIAL-EFFECTS OF PH ON AGONIST AND ANTAGONIST BINDING TO HUMAN-PLATELET THROMBOXANE A2 PROSTAGLANDIN H-2 (TXA2/PGH2) RECEPTORS
    MORINELLI, TA
    MAYEUX, PR
    MAIS, DE
    OATIS, J
    WILLIAMS, T
    HAZARD, S
    BARON, D
    HALUSHKA, PV
    CLINICAL RESEARCH, 1989, 37 (02): : A548 - A548
  • [42] GR85305, A COMBINED THROMBOXANE A2 RECEPTOR BLOCKING DRUG (TXRB) AND TXA2 SYNTHASE INHIBITOR (TXSI) - EFFECTS ON PLATELET-AGGREGATION INVITRO AND INVIVO
    FINCH, H
    PIKE, NB
    WHARTON, KA
    WATTS, IS
    CAMPBELL, I
    COLLINGTON, EW
    LUMLEY, P
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 783 - 783
  • [43] Inhibitory effects of luteolin-4′-O-β-D-glucopyranoside on P2Y12 and thromboxane A2 receptor-mediated amplification of platelet activation in vitro
    Xu, Huanjun
    Lu, Hong
    Zhu, Xiaocui
    Wang, Wei
    Zhang, Zhoumiao
    Fu, Huizheng
    Ma, Shuangcheng
    Luo, Yuehua
    Fu, Jianjiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (01) : 615 - 624
  • [44] INHIBITORY EFFECTS OF OKY-046.HCL, A SELECTIVE THROMBOXANE (TX) A2 SYNTHETASE INHIBITOR, ON PLATELET ACTIVATING FACTOR (PAF)-INDUCED AIRWAY HYPERRESPONSIVENESS IN GUINEA-PIGS
    TAKEHANA, Y
    HAMANO, S
    KIKUCHI, S
    KUSAMA, H
    KOMATSU, H
    OKEGAWA, T
    IKEDA, S
    FOLIA PHARMACOLOGICA JAPONICA, 1990, 95 (01) : 21 - 30
  • [45] EFFECTS OF VERY LOW-DOSES OF ASPIRIN (ASA) ON PLATELET THROMBOXANE-B (PLT TXB2) SYNTHESIS AND ON GASTRIC PROSTAGLANDIN (PG) OUTPUT AND MUCOSAL INJURY IN HUMANS
    LEE, M
    CRYER, B
    FELDMAN, M
    GASTROENTEROLOGY, 1993, 104 (04) : A131 - A131
  • [46] COOPERATIVE EFFECTS OF ARACHIDONIC-ACID (AA) AND PLATELET ACTIVATING FACTOR (PAF-ACETHER) .2. UNEXPECTED RESULTS AFTER ASPIRIN INTAKE
    ALTMAN, R
    SCAZZIOTA, A
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 132 - 132
  • [47] Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study
    Giuseppe Patti
    Marina Polacco
    Ester Taurino
    Carlo Gaudio
    Cesare Greco
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 648 - 653
  • [48] Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study
    Patti, Giuseppe
    Polacco, Marina
    Taurino, Ester
    Gaudio, Carlo
    Greco, Cesare
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 41 (04) : 648 - 653